Literature DB >> 10472417

The physiological approach: functional architecture of working memory and disordered cognition in schizophrenia.

P S Goldman-Rakic1.   

Abstract

The method of single-cell recording in awake behaving monkeys as they perform behavioral tasks is perhaps the most powerful approach to understanding the neural basis of behavior. In contrast to cellular analyses in vitro, e.g., in slice preparations, the in vivo approach allows direct correlation of cellular activity and specific processes as they are isolated by behavioral paradigms. As brain mechanisms are studied under natural conditions, inferences about the dynamic basis of information processing are direct. Limitations of this approach include the inability to unequivocally identify the cell under investigation, though location by cytoarchitectonic area and cortical depth is possible. Neurophysiological studies have not only given a dynamic view of neural processing "on line" but have allowed investigators to examine fundamental issues about normal brain function and dementia. Here I illustrate some of these issues and the power of single cell physiology to address them. Before doing so, it should be patently obvious that recording one cell at a time is a technical necessity and in no way should be taken to imply that any behavior is dependent on a single cell. Rather the neuron investigated is a representative of a cohort of cells acting in aggregate.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10472417     DOI: 10.1016/s0006-3223(99)00130-4

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  101 in total

1.  Selective coupling of T-type calcium channels to SK potassium channels prevents intrinsic bursting in dopaminergic midbrain neurons.

Authors:  Jakob Wolfart; Jochen Roeper
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

2.  I(h) channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain.

Authors:  Henrike Neuhoff; Axel Neu; Birgit Liss; Jochen Roeper
Journal:  J Neurosci       Date:  2002-02-15       Impact factor: 6.167

3.  Basolateral amygdala-driven augmentation of medial prefrontal cortex GABAergic neurotransmission in response to environmental stimuli associated with cocaine administration.

Authors:  Vladimir I Chefer; Ruizhong Wang; Toni S Shippenberg
Journal:  Neuropsychopharmacology       Date:  2011-06-01       Impact factor: 7.853

4.  Synaptic basis of persistent activity in prefrontal cortex in vivo and in organotypic cultures.

Authors:  Jeremy K Seamans; Lourdes Nogueira; Antonieta Lavin
Journal:  Cereb Cortex       Date:  2003-11       Impact factor: 5.357

5.  Relationship between dose, drug levels, and D2 receptor occupancy for the atypical antipsychotics risperidone and paliperidone.

Authors:  E C Muly; J R Votaw; J Ritchie; L L Howell
Journal:  J Pharmacol Exp Ther       Date:  2012-01-03       Impact factor: 4.030

6.  Age- and duration-dependent effects of MPTP on cortical serotonin systems.

Authors:  Twum A Ansah; Marcus C Ferguson; Tultul Nayyar; Ariel Y Deutch
Journal:  Neurosci Lett       Date:  2011-09-21       Impact factor: 3.046

Review 7.  Oxytocin and social cognition in affective and psychotic disorders.

Authors:  M Mercedes Perez-Rodriguez; Katie Mahon; Manuela Russo; Allison K Ungar; Katherine E Burdick
Journal:  Eur Neuropsychopharmacol       Date:  2014-08-01       Impact factor: 4.600

8.  Memory for drug-related visual stimuli in young adult, cocaine-dependent polydrug users.

Authors:  Suchismita Ray; Robert Pandina; Marsha E Bates
Journal:  Am J Drug Alcohol Abuse       Date:  2014-03       Impact factor: 3.829

Review 9.  Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia.

Authors:  David A Lewis; Takanori Hashimoto; Harvey M Morris
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

Review 10.  Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.

Authors:  José A Apud; Daniel R Weinberger
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.